Literature DB >> 23480609

Burkholderia oklahomensis agglutinin is a canonical two-domain OAA-family lectin: structures, carbohydrate binding and anti-HIV activity.

Matthew J Whitley1, William Furey, Sireesha Kollipara, Angela M Gronenborn.   

Abstract

Burkholderia oklahomensis EO147 agglutinin (BOA) is a 29 kDa member of the Oscillatoria agardhii agglutinin (OAA) family of lectins. Members of the OAA family recognize high-mannose glycans, and, by binding to the HIV envelope glycoprotein 120 (gp120), block the virus from binding to and entering the host cell, thereby inhibiting infection. OAA-family lectins comprise either one or two homologous domains, with a single domain possessing two glycan binding sites. We solved the structure of BOA in the ligand-free form as well as in complex with four molecules of 3α,6α-mannopentaose, the core unit of the N-linked high-mannose structures found on gp120 in vivo. This is the first structure of a double-domain OAA-family lectin in which all four binding sites are occupied by ligand. The structural details of the BOA-glycan interactions presented here, together with determination of affinity constants and HIV inactivation data, shed further light onto the structure-function relationship in this important class of anti-HIV proteins.
© 2013 The Authors Journal compilation © 2013 FEBS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480609      PMCID: PMC3745830          DOI: 10.1111/febs.12229

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  39 in total

1.  Novel fold and carbohydrate specificity of the potent anti-HIV cyanobacterial lectin from Oscillatoria agardhii.

Authors:  Leonardus M I Koharudin; William Furey; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

2.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

3.  Burkholderia oklahomensis sp. nov., a Burkholderia pseudomallei-like species formerly known as the Oklahoma strain of Pseudomonas pseudomallei.

Authors:  Mindy B Glass; Arnold G Steigerwalt; Jean G Jordan; Patricia P Wilkins; Jay E Gee
Journal:  Int J Syst Evol Microbiol       Date:  2006-09       Impact factor: 2.747

4.  Purification and characterization of a novel lectin from a freshwater cyanobacterium, Oscillatoria agardhii.

Authors:  Y Sato; M Murakami; K Miyazawa; K Hori
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2000-02       Impact factor: 2.231

5.  Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.

Authors:  Kalyan Das; Arthur D Clark; Paul J Lewi; Jan Heeres; Marc R De Jonge; Lucien M H Koymans; H Maarten Vinkers; Frederik Daeyaert; Donald W Ludovici; Michael J Kukla; Bart De Corte; Robert W Kavash; Chih Y Ho; Hong Ye; Mark A Lichtenstein; Koen Andries; Rudi Pauwels; Marie-Pierre De Béthune; Paul L Boyer; Patrick Clark; Stephen H Hughes; Paul A J Janssen; Eddy Arnold
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

6.  Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.

Authors:  Rob J Center; Richard D Leapman; Jacob Lebowitz; Larry O Arthur; Patricia L Earl; Bernard Moss
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

Authors:  Martin Markowitz; Bach-Yen Nguyen; Eduardo Gotuzzo; Fernando Mendo; Winai Ratanasuwan; Colin Kovacs; Guillermo Prada; Javier O Morales-Ramirez; Clyde S Crumpacker; Robin D Isaacs; Lucinda R Gilde; Hong Wan; Michael D Miller; Larissa A Wenning; Hedy Teppler
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

8.  Pre-calculated protein structure alignments at the RCSB PDB website.

Authors:  Andreas Prlic; Spencer Bliven; Peter W Rose; Wolfgang F Bluhm; Chris Bizon; Adam Godzik; Philip E Bourne
Journal:  Bioinformatics       Date:  2010-10-10       Impact factor: 6.937

9.  Broad neutralization coverage of HIV by multiple highly potent antibodies.

Authors:  Laura M Walker; Michael Huber; Katie J Doores; Emilia Falkowska; Robert Pejchal; Jean-Philippe Julien; Sheng-Kai Wang; Alejandra Ramos; Po-Ying Chan-Hui; Matthew Moyle; Jennifer L Mitcham; Phillip W Hammond; Ole A Olsen; Pham Phung; Steven Fling; Chi-Huey Wong; Sanjay Phogat; Terri Wrin; Melissa D Simek; Wayne C Koff; Ian A Wilson; Dennis R Burton; Pascal Poignard
Journal:  Nature       Date:  2011-09-22       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  13 in total

1.  Sampling of Glycan-Bound Conformers by the Anti-HIV Lectin Oscillatoria agardhii agglutinin in the Absence of Sugar.

Authors:  Marta G Carneiro; Leonardus M I Koharudin; David Ban; T Michael Sabo; Pablo Trigo-Mourino; Adam Mazur; Christian Griesinger; Angela M Gronenborn; Donghan Lee
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-14       Impact factor: 15.336

Review 2.  Molecularly imprinted materials for glycan recognition and processing.

Authors:  Yan Zhao
Journal:  J Mater Chem B       Date:  2022-09-15       Impact factor: 7.571

3.  Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral Hemagglutinin.

Authors:  Yuichiro Sato; Kinjiro Morimoto; Takanori Kubo; Takemasa Sakaguchi; Akira Nishizono; Makoto Hirayama; Kanji Hori
Journal:  Mar Drugs       Date:  2015-05-29       Impact factor: 5.118

4.  A Novel High-Mannose Specific Lectin from the Green Alga Halimeda renschii Exhibits a Potent Anti-Influenza Virus Activity through High-Affinity Binding to the Viral Hemagglutinin.

Authors:  Jinmin Mu; Makoto Hirayama; Yuichiro Sato; Kinjiro Morimoto; Kanji Hori
Journal:  Mar Drugs       Date:  2017-08-16       Impact factor: 5.118

Review 5.  Antiviral lectins: Selective inhibitors of viral entry.

Authors:  Carter A Mitchell; Koreen Ramessar; Barry R O'Keefe
Journal:  Antiviral Res       Date:  2017-03-18       Impact factor: 5.970

Review 6.  Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.

Authors:  Annick Barre; Els J M Van Damme; Mathias Simplicien; Hervé Benoist; Pierre Rougé
Journal:  Mar Drugs       Date:  2020-10-29       Impact factor: 5.118

Review 7.  Human lectins and their roles in viral infections.

Authors:  Christopher P Mason; Alexander W Tarr
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

8.  High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.

Authors:  Makoto Hirayama; Hiromi Shibata; Koji Imamura; Takemasa Sakaguchi; Kanji Hori
Journal:  Mar Biotechnol (NY)       Date:  2015-12-12       Impact factor: 3.619

9.  Anti-influenza virus activity of high-mannose binding lectins derived from genus Pseudomonas.

Authors:  Kinjiro Morimoto; Yuichiro Sato
Journal:  Virus Res       Date:  2016-06-29       Impact factor: 3.303

10.  High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.

Authors:  Makoto Hirayama; Hiromi Shibata; Koji Imamura; Takemasa Sakaguchi; Kanji Hori
Journal:  Mar Biotechnol (NY)       Date:  2015-11-23       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.